紫杉醇联合奈达铂在老年食管癌的疗效分析  

Analysis Curative Effect of Taxol Combine With Eugene Nida in Senium Patients With Esophagus Cancer

作　　者：陈文玲[1] 

机构地区：[1]邢台医学高等专科学校第二附属医院放疗科室,河北邢台054000

出　　处：《中国继续医学教育》2016年第13期170-171,共2页China Continuing Medical Education

摘　　要：目的探究紫杉醇联合奈达铂治疗老年食管癌的临床疗效。方法根据治疗方案不同将66例老年食管癌患者分为A组(36例)和B组(30例),分别给予紫杉醇联合奈达铂和紫杉醇联合顺铂,比较两组近期疗效、毒副反应及1、2年内生存率。结果 A组毒副反应发生率低于B组,1、2年生存率均高于B组,差异有统计学意义(P<0.05)。结论对于老年晚期食管癌,多采用紫杉醇联合奈达铂治疗,近期疗效和耐受性均较高,可提高患者生存率。Objective Analysis curative effect of taxol combine with eugene nida in senium patients with esophagus cancer.Methods 66 cases of elderly patients with esophageal cancer, which were divided into group A （36 cases） and group B （30 cases）, were given nida, paclitaxel plus cisplatin and paclitaxel combined cisplatin, compared two groups in the near future curative effect, adverse reaction and 1, 2 year survival rate.Results The incidence of adverse reaction of group A is lower than group B, 1, 2 year survival rates were higher than group B, the more significant difference （P〈0.05）.Conclusion The elderly advanced esophageal cancer, with paclitaxel plus platinum chemotherapy treatment pattern, the recent high efficacy and tolerability, can improve patients survival rate.

关 键 词：老年食管癌 紫杉醇 奈达铂 近期疗效 

分 类 号：R735.1[医药卫生—肿瘤]